Literature DB >> 28474687

Therapy: Liraglutide - preventing or postponing T2DM diagnosis?

Tina Vilsbøll1, Filip K Knop2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28474687     DOI: 10.1038/nrendo.2017.55

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.

Authors:  Carel W le Roux; Arne Astrup; Ken Fujioka; Frank Greenway; David C W Lau; Luc Van Gaal; Rafael Violante Ortiz; John P H Wilding; Trine V Skjøth; Linda Shapiro Manning; Xavier Pi-Sunyer
Journal:  Lancet       Date:  2017-02-23       Impact factor: 79.321

2.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

Review 3.  The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.

Authors:  L Blonde; D Russell-Jones
Journal:  Diabetes Obes Metab       Date:  2009-12       Impact factor: 6.577

4.  Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.

Authors:  T A Wadden; P Hollander; S Klein; K Niswender; V Woo; P M Hale; L Aronne
Journal:  Int J Obes (Lond)       Date:  2013-07-01       Impact factor: 5.095

Review 5.  Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

Authors:  Rohan Khera; Mohammad Hassan Murad; Apoorva K Chandar; Parambir S Dulai; Zhen Wang; Larry J Prokop; Rohit Loomba; Michael Camilleri; Siddharth Singh
Journal:  JAMA       Date:  2016-06-14       Impact factor: 56.272

Review 6.  Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities.

Authors:  Asger Lund; Filip K Knop; Tina Vilsbøll
Journal:  Eur J Intern Med       Date:  2014-03-30       Impact factor: 4.487

7.  The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates.

Authors:  Ryan K Masters; Eric N Reither; Daniel A Powers; Y Claire Yang; Andrew E Burger; Bruce G Link
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

Review 8.  Prediabetes: a high-risk state for diabetes development.

Authors:  Adam G Tabák; Christian Herder; Wolfgang Rathmann; Eric J Brunner; Mika Kivimäki
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

9.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.